Emerging treatments
Ustekinumab
Ustekinumab may be effective for the treatment of oral ulcers associated with Behcet disease.[32] Reported adverse events include headache and asthenia. Prospective randomized controlled trials are required.
Use of this content is subject to our disclaimer